G. Fumo

17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells.

L. Neckers, D. Metcalfe, C. Akin, 2004, Blood.

mast cells down-regulating mutated, constitutively activated KIT protein in human 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in

L. Neckers, D. Metcalfe, C. Akin, 2013 .

A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.

Cem Akin, P. Lipsky, L. Neckers, 2004, Blood.